Xadago (Page 7 of 7)
PRINCIPAL DISPLAY PANEL — 50 mg Tablet Bottle Carton
Rx only
NDC 27505-
110 -30
Xadago ® (safinamide) tablets
50 mg
Keep out of reach of children.
30 tablets
US WorldMeds™
PRINCIPAL DISPLAY PANEL — 100 mg Tablet Bottle Carton
Rx only
NDC 27505-
111 -30
Xadago ® (safinamide) tablets
100 mg
Keep out of reach of children.
30 tablets
US WorldMeds™
XADAGO safinamide mesylate tablet, film coated | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
|
XADAGO safinamide mesylate tablet, film coated | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
|
Labeler — MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. (087875626) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Catalent Germany Schorndorf GmbH | 315732628 | manufacture (27505-110), pack (27505-110), manufacture (27505-111), analysis (27505-110), analysis (27505-111), pack (27505-111), label (27505-110), label (27505-111) |
Establishment | |||
Name | Address | ID/FEI | Operations |
BioChem Labor fur biologische und chemische Analytik GmbH | 318354230 | analysis (27505-110), analysis (27505-111) |
Establishment | |||
Name | Address | ID/FEI | Operations |
PHAST Gesellschaft fuer Pharmazeutische Qualitatsstandards mbH | 331156161 | analysis (27505-110), analysis (27505-111) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Merck KGaA | 342249299 | analysis (27505-110), analysis (27505-111), api manufacture (27505-110), api manufacture (27505-111) |
Establishment | |||
Name | Address | ID/FEI | Operations |
PRC Ticinum Lab s.r.l | 437339604 | analysis (27505-110), analysis (27505-111) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Solvias AG | 480739627 | analysis (27505-110), analysis (27505-111) |
Revised: 02/2022 MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.